100
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Differences in cardiovascular event rates between atorvastatin and simvastatin among new users: managed-care experience

, &
Pages 2873-2882 | Accepted 13 Aug 2008, Published online: 29 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (9)

Gaoqiang Xie, Phyo Kyaw Myint, Yihong Sun, Xian Li, Tao Wu, Run-lin Gao & Yangfeng Wu. (2022) Associated factors for discontinuation of statin use one year after discharge in patients with acute coronary syndrome in China. BMJ Open 12:9, pages e056236.
Crossref
Dan Atar, Seleen Ong & Peter J Lansberg. (2015) Expanding the Evidence Base. American Journal of Therapeutics 22:5, pages e141-e150.
Crossref
Anke Neumann, Géric Maura, Alain Weill, Philippe Ricordeau, François Alla & Hubert Allemand. (2013) Comparative effectiveness of rosuvastatin versus simvastatin in primary prevention among new users: a cohort study in the French national health insurance database. Pharmacoepidemiology and Drug Safety 23:3, pages 240-250.
Crossref
Peter P. Toth, JoAnne M. Foody, Joanne E. Tomassini, Shiva G. Sajjan, Dena R. Ramey, David R. Neff, Andrew M. Tershakovec, X. Henry Hu & Kaan Tunceli. (2014) Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease. Journal of Clinical Lipidology 8:1, pages 107-116.
Crossref
Jason P. Swindle, Jesse Potash, Mahesh Kulakodlu, Andreas Kuznik & Ami Buikema. (2011) Drug Utilization Patterns and Cardiovascular Outcomes in Elderly Patients Newly Initiated on Atorvastatin or Simvastatin. The American Journal of Geriatric Pharmacotherapy 9:6, pages 471-482.
Crossref
Ross J Simpson, James Signorovitch, Karthik Ramakrishnan, Jasmina Ivanova, Howard Birnbaum & Andreas Kuznik. (2011) Cardiovascular and Economic Outcomes After Initiation of Atorvastatin versus Simvastatin in an Employed Population Stratified by Cardiovascular Risk. American Journal of Therapeutics 18:6, pages 436-448.
Crossref
Maarit Jaana Korhonen, Arja Helin-Salmivaara & Risto Huupponen. (2011) Dynamics of long-term statin therapy. European Journal of Clinical Pharmacology 67:9, pages 925-931.
Crossref
Kaan Tunceli, Shiva G. Sajjan, Dena R. Ramey, David R. Neff, Andrew M. Tershakovec, X. Henry Hu, Joanne E. Tomassini & JoAnne M. Foody. (2010) Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients. Journal of Clinical Lipidology 4:6, pages 491-500.
Crossref
Ross J. SimpsonJrJr, James Signorovitch, Howard Birnbaum, Jasmina Ivanova, Cristina Connolly, Yohanne Kidolezi & Andreas Kuznik. (2009) Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population. Mayo Clinic Proceedings 84:12, pages 1065-1072.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.